Martin Wartenberg
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 12
- Pancreatic and Hepatic Oncology Research 8
- Cancer Cells and Metastasis 5
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Eva Karamitopoulou (8 shared papers)Inti Zlobec (7 shared papers)Beat Gloor (5 shared papers)Aurel Perren (6 shared papers)Erik Vassella (3 shared papers)Mathias Worni (2 shared papers)Alessandro Lugli (5 shared papers)Micha David Eichmann (1 shared paper)
- Journals
- Histopathology (2 papers)European Journal of Cancer (2 papers)Oncogene (2 papers)Cancer Research (2 papers)Blood (1 paper)
- Partner nations
- SwitzerlandGermanyItaly
In The Last Decade
Martin Wartenberg
25 papers receiving 465 citations
Peers
Comparison fields: 5 of 63
- Oncology 290
- Cancer Research 131
- Immunology 88
- Otorhinolaryngology 17
- Health Informatics 5
Countries citing papers authored by Martin Wartenberg
This map shows the geographic impact of Martin Wartenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Wartenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Wartenberg more than expected).
Fields of papers citing papers by Martin Wartenberg
This network shows the impact of papers produced by Martin Wartenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Wartenberg. The network helps show where Martin Wartenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Wartenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 142 | |
| 2 | 2015 | 53 | |
| 3 | 2016 | 43 | |
| 4 | 2021 | 42 | |
| 5 | 2017 | 36 | |
| 6 | 2018 | 30 | |
| 7 | 2013 | 27 | |
| 8 | 2024 | 21 | |
| 9 | 2016 | 18 | |
| 10 | 2011 | 12 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2022 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2014 | 1 |
About Martin Wartenberg
Martin Wartenberg is a scholar working on Oncology, Cancer Research, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 467 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (5 papers), Protein Degradation and Inhibitors (2 papers), Renal cell carcinoma treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Oncology (290 citations), Cancer Research (131 citations), Immunology (88 citations), Otorhinolaryngology (17 citations) and Health Informatics (5 citations). Martin Wartenberg has collaborated with scholars based in Switzerland, Germany and Italy. Frequent co-authors include Eva Karamitopoulou, Inti Zlobec, Beat Gloor, Aurel Perren, Erik Vassella, Mathias Worni, Alessandro Lugli, Micha David Eichmann, Luigi Terracciano and Serenella Eppenberger‐Castori. Their work appears in journals such as Histopathology, European Journal of Cancer, Oncogene, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.